Elicera Therapeutics AB Financial Overview
Elicera Therapeutics AB's market cap is currently kr285.39M. The company's EPS TTM is kr0.006; its P/E ratio is -16.89; Elicera Therapeutics AB is scheduled to report earnings on November 14, 2025, and the estimated EPS forecast is kr―. See an overview of income statement, balance sheet, and cash flow financials.
